Additox

Active substance: TRIFOLIUM PRATENSE FLOWER, ZANTHOXYLUM AMERICANUM BARK, PHYTOLACCA AMERICANA ROOT, ARSENIC TRIOXIDE, ATROPA BELLADONNA, CHELIDONIUM MAJUS, LYCOPODIUM CLAVATUM SPORE, PHOSPHORIC ACID, ASPARTAME, BENZALKONIUM CHLORIDE, FORMALDEHYDE, METHYLENE CHLORIDE, METHYLPARABEN, PROPYLPARABEN, SODIUM BENZOATE, SODIUM CITRATE, TITANIUM DIOXIDE, ZINC OXIDE

LIQUID · TRIFOLIUM PRATENSE FLOWER 3 [hp_X]/mL, ZANTHOXYLUM AMERICANUM BARK 3 [hp_X]/mL, PHYTOLACCA AMERICANA ROOT 4 [hp_X]/mL, ARSENIC TRIOXIDE 12 [hp_X]/mL, ATROPA BELLADONNA 12 [hp_X]/mL, CHELIDONIUM MAJUS 12 [hp_X]/mL, LYCOPODIUM CLAVATUM SPORE 12 [hp_X]/mL, PHOSPHORIC ACID 12 [hp_X]/mL, ASPARTAME 30 [hp_X]/mL, BENZALKONIUM CHLORIDE 30 [hp_X]/mL, FORMALDEHYDE 30 [hp_X]/mL, METHYLENE CHLORIDE 30 [hp_X]/mL, METHYLPARABEN 30 [hp_X]/mL, PROPYLPARABEN 30 [hp_X]/mL, SODIUM BENZOATE 30 [hp_X]/mL, SODIUM CITRATE 30 [hp_X]/mL, TITANIUM DIOXIDE 30 [hp_X]/mL, ZINC OXIDE 30 [hp_X]/mL

United StatesActive

Marketing holder: BioActive Nutritional, Inc.

Verified 2026-10-09 · openFDA NDC

Analogues in other countries

Source: openFDA NDC
Countries with the substance registered: 2

Composition

TRIFOLIUM PRATENSE FLOWER · 3 [hp_X]/mL
ZANTHOXYLUM AMERICANUM BARK · 3 [hp_X]/mL
PHYTOLACCA AMERICANA ROOT · 4 [hp_X]/mL
ARSENIC TRIOXIDE · 12 [hp_X]/mL
ATROPA BELLADONNA · 12 [hp_X]/mL
CHELIDONIUM MAJUS · 12 [hp_X]/mL
LYCOPODIUM CLAVATUM SPORE · 12 [hp_X]/mL
PHOSPHORIC ACID · 12 [hp_X]/mL
ASPARTAME · 30 [hp_X]/mL
BENZALKONIUM CHLORIDE · 30 [hp_X]/mL
FORMALDEHYDE · 30 [hp_X]/mL
METHYLENE CHLORIDE · 30 [hp_X]/mL
METHYLPARABEN · 30 [hp_X]/mL
PROPYLPARABEN · 30 [hp_X]/mL
SODIUM BENZOATE · 30 [hp_X]/mL
SODIUM CITRATE · 30 [hp_X]/mL
TITANIUM DIOXIDE · 30 [hp_X]/mL
ZINC OXIDE · 30 [hp_X]/mL

Products containing arsenic trioxide in other countries

Showing products with this active substance, combinations included; the full composition is shown for each product.

Country	Products
EU 4	Arsenic trioxide Accord arsenic trioxide EMEA/H/C/005175 Accord Healthcare S.L.U. Arsenic trioxide medac arsenic trioxide EMEA/H/C/005218 medac Gesellschaft für klinische Spezialpräparate mbH Trisenox arsenic trioxide EMEA/H/C/000388 Teva B.V. Arsenic trioxide Mylan arsenic trioxide EMEA/H/C/005235 Mylan Ireland Limited

Registration

Registration number: 43857-0487
Registration status: Active
Dispensing: Over the counter
Route: ORAL

Sources

product · openFDA NDC · 43857-0487 · Verified 2026-10-09 · open in source
registration_status · openFDA NDC · 43857-0487 · Verified 2026-10-09 · open in source
ingredients.0 · openFDA NDC · 43857-0487 · Verified 2026-10-09 · open in source
ingredients.1 · openFDA NDC · 43857-0487 · Verified 2026-10-09 · open in source
ingredients.2 · openFDA NDC · 43857-0487 · Verified 2026-10-09 · open in source
ingredients.3 · openFDA NDC · 43857-0487 · Verified 2026-10-09 · open in source
ingredients.4 · openFDA NDC · 43857-0487 · Verified 2026-10-09 · open in source
ingredients.5 · openFDA NDC · 43857-0487 · Verified 2026-10-09 · open in source
ingredients.6 · openFDA NDC · 43857-0487 · Verified 2026-10-09 · open in source
ingredients.7 · openFDA NDC · 43857-0487 · Verified 2026-10-09 · open in source
ingredients.8 · openFDA NDC · 43857-0487 · Verified 2026-10-09 · open in source
ingredients.9 · openFDA NDC · 43857-0487 · Verified 2026-10-09 · open in source
ingredients.10 · openFDA NDC · 43857-0487 · Verified 2026-10-09 · open in source
ingredients.11 · openFDA NDC · 43857-0487 · Verified 2026-10-09 · open in source
ingredients.12 · openFDA NDC · 43857-0487 · Verified 2026-10-09 · open in source
ingredients.13 · openFDA NDC · 43857-0487 · Verified 2026-10-09 · open in source
ingredients.14 · openFDA NDC · 43857-0487 · Verified 2026-10-09 · open in source
ingredients.15 · openFDA NDC · 43857-0487 · Verified 2026-10-09 · open in source
ingredients.16 · openFDA NDC · 43857-0487 · Verified 2026-10-09 · open in source
ingredients.17 · openFDA NDC · 43857-0487 · Verified 2026-10-09 · open in source